NCT03496844View on ClinicalTrials.gov

Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma

NACompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

April 15, 2018

Primary Completion Date

April 27, 2021

Study Completion Date

April 27, 2021

Conditions

Prostate Adenocarcinoma

Interventions

DIAGNOSTIC_TEST

F-18 fluciclovine-PET/CT scan

PET/CT imaging with F-18 fluciclovine

Trial Locations (1)

85724

University of Arizona, Tucson

Sponsors

Collaborators (1)

Blue Earth Diagnostics

All Listed Sponsors

collaborator

Blue Earth Diagnostics

INDUSTRY

collaborator

Banner University Medical Center

OTHER

lead

University of Arizona

OTHER

NCT03496844 - Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma | Biotech Hunter | Biotech Hunter